Document is current
Any future updates will be listed below
-
Authors
Verdegaal, Els M E https://orcid.org/0000-0002-4449-8707
Santegoets, Saskia J https://orcid.org/0000-0002-2874-4402
Welters, Marij J P
de Bruin, Linda
Visser, Marten
van der Minne, Caroline E
de Kok, Pita M
Loof, Nikki M
Boekestijn, Sanne
Roozen, Inge
Westra, Inge M
Meij, Pauline
Van der Burg, Sjoerd H https://orcid.org/0000-0002-6556-0354
Kroep, Judith R https://orcid.org/0000-0003-2671-1903
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04072263 at ClinicalTrials.govnct04072263 at ClinicalTrials.govDocuments that mention this clinical trial
356 Personalized immunotherapy by adoptive T cell transfer during chemotherapy with or without interferon-alpha in patients with recurrent platinum-sensitive epithelial ovarian cancer
https://doi.org/10.1136/jitc-2021-sitc2021.356
PO008/#393 Timed adoptive T-cell therapy during chemotherapy in platinum sensitive recurrent epithelial ovarian cancer, the ovacure phase I/II trial
https://doi.org/10.1136/ijgc-2023-igcs.8
The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee
https://doi.org/10.1136/jitc-2025-013420
Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer
https://doi.org/10.1136/jitc-2023-007697
nct04072263 at ClinicalTrials.govDocuments that mention this clinical trial
356 Personalized immunotherapy by adoptive T cell transfer during chemotherapy with or without interferon-alpha in patients with recurrent platinum-sensitive epithelial ovarian cancer
https://doi.org/10.1136/jitc-2021-sitc2021.356
PO008/#393 Timed adoptive T-cell therapy during chemotherapy in platinum sensitive recurrent epithelial ovarian cancer, the ovacure phase I/II trial
https://doi.org/10.1136/ijgc-2023-igcs.8
The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee
https://doi.org/10.1136/jitc-2025-013420
Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer
https://doi.org/10.1136/jitc-2023-007697
Documents that mention this clinical trial
356 Personalized immunotherapy by adoptive T cell transfer during chemotherapy with or without interferon-alpha in patients with recurrent platinum-sensitive epithelial ovarian cancer
https://doi.org/10.1136/jitc-2021-sitc2021.356
PO008/#393 Timed adoptive T-cell therapy during chemotherapy in platinum sensitive recurrent epithelial ovarian cancer, the ovacure phase I/II trial
https://doi.org/10.1136/ijgc-2023-igcs.8
The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee
https://doi.org/10.1136/jitc-2025-013420
Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer
https://doi.org/10.1136/jitc-2023-007697
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding (2021-13673)
Ovacure Foundation (n/a)
- License Information
